Eclipse MedCorp Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Eclipse MedCorp's estimated annual revenue is currently $18.8M per year.
- Eclipse MedCorp's estimated revenue per employee is $251,000
- Eclipse MedCorp has 75 Employees.
- Eclipse MedCorp grew their employee count by 12% last year.
- Eclipse MedCorp currently has 1 job openings.
What Is Eclipse MedCorp?
Eclipse is a proven innovator with an award-winning reputation for bringing ground-breaking products to market. We provide products that exceed patient expectations and result in immediate success for practices. We believe in delivering leading-edge technology, education and results. We offer top-selling products for simple yet prolific procedures that are both affordable and efficacious. Eclipse strives to advance science and success though education for our customers by providing grants for courses, research, studies and offering continuing education through training, events and conferences. Practice and patient success is our ultimate goal. In order to ensure our customers' success and meet ever-growing product demand, Eclipse has amassed a team of dedicated managers and sales representatives to promote the company's highly sought after medical devices and aesthetic specialty supplies. Customers we assist include: dermatologist, plastic surgeons, cosmetic physicians, aestheticians and skin care professionals. The company provides a variety of best-selling products, including: Eclipse PRP®, platelet-rich plasma kits; Theradome®, laser hair helmet; the Eclipse MicroPen® micro-needling device (not available in every country), Eclipse MicroGlide GF and a variety of post-care and skin-care products. Eclipse is thriving and growing both in the United States and globally. The company has become an international supplier of its highly popular products, including Eclipse PRP and the Eclipse MicroPen®. Distribution channels have been established in Canada, Australia, Saudi Arabia, UAE, Egypt, Mexico, Columbia and beyond.keywords:N/A